Demyelination in Vascular Dementia: Focus on Oligodendrocytes, Microglia, and Their Interaction

Ying Liu1, Jiaming Li1, Yang Zhao1

  • 1School of Traditional Chinese Medicine Department, Beijing University of Chinese Medicine, Beijing, 100029, China.

Insights

Vascular dementia involves myelin damage due to poor brain blood flow. Dysfunctional communication between oligodendrocytes and microglia, via complement, cytokines, and vesicles, drives this damage, impacting cognitive decline.

Area of Science:

  • Neuroscience
  • Immunology
  • Pathology

Background:

  • Vascular dementia (VaD) is a cognitive disorder linked to cerebrovascular issues and white matter damage.
  • Myelin integrity loss, driven by dysfunctional oligodendrocytes (OLs) and microglia (MG), is central to VaD pathology.
  • Cellular communication via the complement system, cytokines, and extracellular vesicles is vital for neural homeostasis.

Purpose of the Study:

  • To review the complex interplay between OLs and MG in VaD demyelination.
  • To detail the communication networks involving the complement system, cytokines, and extracellular vesicles in VaD.
  • To highlight the bidirectional nature of these interactions and their impact on neuroinflammation and repair.

Main Methods:

  • Literature review focusing on cellular interactions in VaD.
  • Analysis of communication pathways: complement system (C1q, C3, C5), cytokines (TNF-α, IL-1β, IL-4, IL-10), and extracellular vesicles.
  • Examination of the role of these pathways in myelin maintenance and damage.

Main Results:

  • Dysfunctional OLs and MG form a pathogenic nexus in VaD.
  • Aberrant signaling through complement, cytokines, and EVs disrupts neural microenvironment homeostasis.
  • Both repair and injury are influenced by the activation levels of these communication pathways.

Conclusions:

  • OL-MG communication networks are critical in VaD-associated demyelination.
  • Dysregulation of these networks promotes neuroinflammation and tissue damage.
  • Targeting these specific communication pathways offers potential for novel VaD therapeutic strategies.

Related Concept Videos

Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Nervous Tissue: Myelin01:25

Nervous Tissue: Myelin

The myelin sheath is a multilayered lipid and protein covering that insulates the axon of a neuron, enhancing the speed of nerve impulse conduction. Axons without this sheath are referred to as unmyelinated. Two types of neuroglia, Schwann cells in the peripheral nervous system (PNS) and oligodendrocytes in the central nervous system (CNS) are responsible for producing myelin sheaths.
Schwann cells begin to form myelin sheaths around axons during fetal development. They wrap around a small...